SCLX

Scilex Holding Co (ticker: SCLX) is an NASDAQ-listed clinical research company. DredgeCap's structured extraction of SCLX's SEC filings surfaces 7 active risk signals, including 4 late-filing signals, 2 auditor-change signals, and 1 delisting/deregistration signal. SCLX reported $30.25M in revenue and -$374.05M for the period ending 2025-12-31, with operating cash flow of $3.82M. Cash and equivalents stood at $4.96M (up 51.4% year-over-year). Total assets of $364.98M are exceeded by total liabilities of $576.73M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.